Literature DB >> 18308549

Acute normovolemic hemodilution, intraoperative cell salvage and PulseCO hemodynamic monitoring in a Jehovah's Witness with placenta percreta.

C J Nagy1, A S Wheeler, T L Archer.   

Abstract

A Jehovah's Witness who had had four previous cesarean deliveries was referred to our institution for management of a complete placenta previa at 34 weeks of gestation. A subsequent ultrasound scan was suggestive of placenta percreta with bladder involvement. After erythropoietin and iron supplementation, cesarean hysterectomy was performed. Using PulseCO technology for continuous hemodynamic monitoring, preoperative acute normovolemic hemodilution and intraoperative cell salvage were used resulting in a successful cesarean hysterectomy with a 5500-mL estimated blood loss. The PulseCO system provides continuous, real-time hemodynamic data by applying pulse power analysis to the arterial pressure waveform. A bolus of oxytocin given after delivery produced profound hypotension, the hemodynamics of which were elucidated with the PulseCO system. To our knowledge, the combined use of acute normovolemic hemodilution, intraoperative cell salvage and PulseCO hemodynamic monitoring for cesarean hysterectomy has not been reported previously. These techniques may be particularly useful in managing patients who refuse blood products and/or in whom the baseline hemoglobin is suboptimal.

Entities:  

Mesh:

Year:  2008        PMID: 18308549     DOI: 10.1016/j.ijoa.2007.07.005

Source DB:  PubMed          Journal:  Int J Obstet Anesth        ISSN: 0959-289X            Impact factor:   2.603


  5 in total

Review 1.  Autologous blood in obstetrics: where are we going now?

Authors:  Giancarlo Maria Liumbruno; Chiara Liumbruno; Daniela Rafanelli
Journal:  Blood Transfus       Date:  2011-10-25       Impact factor: 3.443

Review 2.  [Recent standards in management of obstetric anesthesia].

Authors:  Maximiliaan van Erp; Clemens Ortner; Stefan Jochberger; Klaus Ulrich Klein
Journal:  Wien Med Wochenschr       Date:  2017-07-25

3.  Obstetric outcomes and acceptance of alternative therapies to blood transfusion by Jehovah's Witnesses in Japan: a single-center study.

Authors:  Mie Tanaka; Shinya Matsuzaki; Masayuki Endo; Aiko Kakigano; Kazuya Mimura; Tsuyoshi Takiuchi; Tatsuya Miyake; Takuji Tomimatsu; Yutaka Ueda; Tadashi Kimura
Journal:  Int J Hematol       Date:  2018-06-29       Impact factor: 2.490

4.  Comparison between nitroglycerin and remifentanil in acute hypervolemic hemodilution combined with controlled hypotension during intracranial aneurysm surgery.

Authors:  Xuekang Zhang; Qian Hu; Zhiyi Liu; Haijin Huang; Qin Zhang; Hanying Dai
Journal:  Int J Clin Exp Med       Date:  2015-10-15

5.  Management of placenta percreta in a Jehovah's Witness patient.

Authors:  Adriana J Wong; Matthew Schlumbrecht; Marilyn Huang
Journal:  BMJ Case Rep       Date:  2018-06-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.